Tauriga Sciences Inc. Completes Acquisition of Innovative Synthetic Biology Firm Pilus Energy LLC and Positions Itself in Nascent $10 Billion Annual Wastewater-to-Value Market
January 28, 2014 09:01 ET
|
Tauriga Sciences Inc
CINCINNATI, Jan. 28, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license...
Tauriga Sciences Inc. Appoints Mr. Jason E. Barkeloo as Member of the Company's Business Advisory Board
January 27, 2014 07:59 ET
|
Tauriga Sciences Inc
CINCINNATI, Jan. 27, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license...
Tauriga Sciences Inc. Highlights Pilus Energy's Genetic Rights Management ("GeRM") Keys for the Protection of Its Synthetic Biology Based BactoBots(TM)
January 24, 2014 09:10 ET
|
Tauriga Sciences Inc
NEW YORK, Jan. 24, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license...
Tauriga Sciences Inc. Repays and Retires Convertible Note Held by Asher Enterprises, Inc. for Principal Amount of $37,500 USD and Issues Important Clarification to Shareholders
January 21, 2014 17:59 ET
|
Tauriga Sciences Inc
NEW YORK, Jan. 21, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license...
Tauriga Sciences Inc. Receives Product Engineering Plan for Polychlorinated Biphenyl Remediating BactoBots(TM) for the Nuclear Industry ("NuclearBot(TM)")
January 21, 2014 09:02 ET
|
Tauriga Sciences Inc
NEW YORK, Jan. 21, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license...
Tauriga Sciences, Inc. Elects to Purchase Key Man Insurance Policies for Both Its Chief Executive Officer and Chief Operating Officer for $6,000,000 USD and $3,000,000 USD Respectively
January 17, 2014 08:15 ET
|
Tauriga Sciences Inc
DANBURY, Conn., Jan. 17, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license...
Tauriga Sciences Inc. Presents Detailed Illustration of Pilus Energy's GalvaniBot(TM) Powered Electrogenic Bioreactor Waste-to-Value Technology Platform
January 16, 2014 07:50 ET
|
Tauriga Sciences Inc
SAN FRANCISCO, Jan. 16, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license...
Tauriga Sciences Inc. Focused on Securing Several Potential Sources of Non-Dilutive Funding
January 08, 2014 07:45 ET
|
Tauriga Sciences Inc
NEW YORK, Jan. 8, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license...
Tauriga Sciences Inc. Invited to Present at 24th Annual Institutional Investor Conference on March 03, 2014 at The University Club in New York City
January 03, 2014 09:00 ET
|
Tauriga Sciences Inc
NEW YORK, Jan. 3, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license...
Tauriga Sciences Inc. Receives Positive Update From Immunovative Therapies Ltd. and Expected Start Date for Pivotal Phase II/III Breast Cancer Trial
January 03, 2014 08:10 ET
|
Tauriga Sciences Inc
NEW YORK, Jan. 3, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license...